scholarly article | Q13442814 |
P356 | DOI | 10.1111/VCO.12139 |
P698 | PubMed publication ID | 25623994 |
P50 | author | Riccardo Finotello | Q43078298 |
Damiano Stefanello | Q52991033 | ||
Laura Marconato | Q57015396 | ||
P2093 | author name string | E Zini | |
P2860 | cites work | Epirubicin in the adjuvant treatment of splenic hemangiosarcoma in dogs: 59 cases (1997-2004). | Q33377434 |
Dacarbazine as single-agent therapy for relapsed lymphoma in dogs | Q33385994 | ||
Predictors of outcome in dogs with subcutaneous or intramuscular hemangiosarcoma | Q33394136 | ||
Dose-Dense Chemotherapy: Principles, Clinical Results and Future Perspectives | Q34284284 | ||
Emerging therapies for adult soft tissue sarcoma. | Q34659806 | ||
Illness severity scores in veterinary medicine: what can we learn? | Q37718934 | ||
Chemotherapy of canine hemangiosarcoma with doxorubicin and cyclophosphamide | Q40710909 | ||
Treatment of relapsed canine lymphoma with doxorubicin and dacarbazine | Q43511081 | ||
Treatment of vascular and soft-tissue sarcomas in dogs using an alternating protocol of ifosfamide and doxorubicin. | Q46044456 | ||
Evaluation of outcome associated with subcutaneous and intramuscular hemangiosarcoma treated with adjuvant doxorubicin in dogs: 21 cases (2001-2006). | Q46507967 | ||
Combination of CCNU and DTIC chemotherapy for treatment of resistant lymphoma in dogs | Q46742182 | ||
The "old drug" dacarbazine as a second/third line chemotherapy in advanced soft tissue sarcomas | Q46979293 | ||
Surgery and doxorubicin in dogs with hemangiosarcoma. | Q50987636 | ||
The calculation of actual or received dose intensity: a comparison of published methods. | Q52437931 | ||
P433 | issue | 1 | |
P304 | page(s) | 25-35 | |
P577 | publication date | 2015-01-26 | |
P1433 | published in | Veterinary and Comparative Oncology | Q15759976 |
P1476 | title | Comparison of doxorubicin-cyclophosphamide with doxorubicin-dacarbazine for the adjuvant treatment of canine hemangiosarcoma. | |
P478 | volume | 15 |
Q47299200 | Anticancer effects of resveratrol in canine hemangiosarcoma cell lines. |
Q47101799 | Beta Adrenergic Signaling: A Targetable Regulator of Angiosarcoma and Hemangiosarcoma |
Q91168663 | Dendritic cell vaccination plus low-dose doxorubicin for the treatment of spontaneous canine hemangiosarcoma |
Q92379575 | Hepatic Hemangiosarcoma in a Cynomolgus Macaque (Macaca fascicularis) |
Q39373386 | Survey of UK-based veterinary surgeons' opinions on the use of surgery and chemotherapy in the treatment of canine high-grade mast cell tumour, splenic haemangiosarcoma and appendicular osteosarcoma. |
Search more.